As a result of the current Federal government funding situation, the information on this website may not be up to date or acted upon. Updates regarding government operating status and resumption of normal operations can be found at www.opm.gov . Despite the lapse in appropriations, IHS will continue to provide direct clinical health care services as well as referrals for contracted services that cannot be provided through IHS clinics. For more information on how IHS is impacted, visit: HHS Contingency Plan
Tobacco Use Screening
Commercial tobacco use increases the risk of cardiovascular disease, microvascular complications, and premature death. Cessation of tobacco use reduces the risk of stroke and heart attack. Screening for tobacco use in people with diabetes helps programs connect patients/participants with tobacco cessation interventions.
Required Key Measure
Must be reported by grantees that select this Best Practice.
Number and percent of individuals in your Target Group who are screened for tobacco use.
- Improvement: Increasing the number and percent of individuals in your Target Group who achieve this measure shows improvement.
- Timeframe: The timeframe for collecting data on the Required Key Measure will be January 1st to December 31st.
- Data Collection: For more information on data collection and reporting, see the SDPI Outcomes System (SOS).
Optional Supporting Measures
These measures are NOT required, but help to provide a more complete assessment of tobacco use status in your Target Group.
Number and percent of individuals in your Target Group who:
- Are current tobacco users.
Note: This measure will help you identify individuals in your Target Group who need cessation counseling, if not already done.
- Are current tobacco users with documented cessation counseling or referral.
Note: Increasing the number and percent of individuals in your Target Group who achieve this measure shows improvement.
Target Group Guidance
Select your Target Group from adults and/or youth with diabetes or at risk for developing diabetes.
You are required to report Required Key Measure data for one Target Group for your selected Best Practice. A Target Group is the largest number of patients/participants that your grant program can realistically serve. The following should be considered in selecting your Target Group:
- The size and characteristics (e.g., ages, health status, settings) of the community or patient population that you are going to draw your Target Group from
- Intensity of the activities/services you plan to do
- SDPI funding and other resources available to provide activities/services
For information and examples on selecting a Target Group, see the SDPI Diabetes Best Practice and Target Group recorded webinar.
Resources and Tools
Below are selected resources and tools specific to this Best Practice. Additional resources that may be useful for all Best Practices can be found in the SDPI Best Practice Resources.
IHS Division of Diabetes Treatment and Prevention
Alaska Native Tribal Health Consortium
American Diabetes Association
Centers for Disease Control and Prevention
National Library of Medicine
Office of the Surgeon General, Department of Health and Human Services